首页> 美国卫生研究院文献>Biopreservation and Biobanking >A Review of International Biobanks and Networks: Success Factors and Key Benchmarks
【2h】

A Review of International Biobanks and Networks: Success Factors and Key Benchmarks

机译:国际生物库和网络回顾:成功因素和关键基准

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Biobanks and biobanking networks are involved in varying degrees in the collection, processing, storage, and dissemination of biological specimens. This review outlines the approaches that 16 of the largest biobanks and biobanking networks in Europe, North America, Australia, and Asia have taken to collecting and distributing human research specimens and managing scientific initiatives while covering operating costs. Many are small operations that exist as either a single or a few freezers in a research laboratory, hospital clinical laboratory, or pathology suite. Larger academic and commercial biobanks operate to support large clinical and epidemiological studies. Operational and business models depend on the medical and research missions of their institutions and home countries. Some national biobanks operate with a centralized physical biobank that accepts samples from multiple locations. Others operate under a “federated” model where each institution maintains its own collections but agrees to list them on a central shared database. Some collections are “project-driven” meaning that specimens are collected and distributed to answer specific research questions. “General” collections are those that exist to establish a reference collection, that is, not to meet particular research goals but to be available to respond to multiple requests for an assortment of research uses. These individual and networked biobanking systems operate under a variety of business models, usually incorporating some form of partial cost recovery, while requiring at least partial public or government funding. Each has a well-defined biospecimen-access policy in place that specifies requirements that must be met—such as ethical clearance and the expertise to perform the proposed experiments—to obtain samples for research. The success of all of these biobanking models depends on a variety of factors including well-defined goals, a solid business plan, and specimen collections that are developed according to strict quality and operational controls.
机译:生物样本库和生物样本库网络在不同程度上涉及生物样本的收集,处理,存储和传播。这篇综述概述了欧洲,北美,澳大利亚和亚洲的16个最大的生物库和生物库网络采用的方法,以收集和分发人类研究标本并管理科学计划,同时覆盖运营成本。许多是小型的操作,在研究实验室,医院临床实验室或病理学套件中以单个或几个冷冻机的形式存在。较大的学术和商业生物库可为大型临床和流行病学研究提供支持。运营和商业模式取决于其机构和母国的医疗和研究任务。一些国家生物库与一个集中的物理生物库一起运作,该生物库从多个位置接收样本。其他机构则采用“联合”模式运作,每个机构都维护自己的馆藏,但同意在中央共享数据库中列出这些馆藏。有些馆藏是“项目驱动的”,这意味着需要收集和分发标本来回答特定的研究问题。 “一般”馆藏是为了建立参考馆藏而存在的,即不满足特定的研究目标,而是可用来响应多种研究用途的多种要求。这些单独的和联网的生物银行系统在各种商业模式下运行,通常会结合某种形式的部分成本回收,同时至少需要部分公共或政府资金。每个实验室都有一个明确定义的生物样本获取策略,该策略指定必须满足的要求(例如道德规范和执行建议的实验的专业知识)才能获得用于研究的样本。所有这些生物库模型的成功取决于多种因素,包括明确的目标,可靠的业务计划以及根据严格的质量和操作控制开发的标本集合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号